Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Envoy Medical (COCH) Receivables (2022 - 2026)

Envoy Medical's Receivables history spans 5 years, with the latest figure at $48000.0 for Q1 2026.

  • On a quarterly basis, Receivables fell 26.15% to $48000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $48000.0, a 26.15% decrease, with the full-year FY2025 number at $53000.0, down 93.52% from a year prior.
  • Receivables hit $48000.0 in Q1 2026 for Envoy Medical, down from $53000.0 in the prior quarter.
  • Over the last five years, Receivables for COCH hit a ceiling of $1.1 million in Q3 2023 and a floor of $41000.0 in Q4 2022.
  • Historically, Receivables has averaged $262416.7 across 5 years, with a median of $133500.0 in 2024.
  • Biggest five-year swings in Receivables: surged 500.0% in 2023 and later tumbled 93.52% in 2025.
  • Tracing COCH's Receivables over 5 years: stood at $41000.0 in 2022, then surged by 500.0% to $246000.0 in 2023, then soared by 232.52% to $818000.0 in 2024, then tumbled by 93.52% to $53000.0 in 2025, then decreased by 9.43% to $48000.0 in 2026.
  • Business Quant data shows Receivables for COCH at $48000.0 in Q1 2026, $53000.0 in Q4 2025, and $54000.0 in Q3 2025.